Objective
The primary objective of the meta-trial is to investigate whether inhaled nebulised UFH in hospitalised patients with COVID-19 who do not require immediate invasive mechanical ventilation, significantly reduces rates of intubation (or death, for patients who died before intubation) at day 28, compared to standard care alone. Primary outcomes for individual studies may be different clinical or biochemical endpoints and are listed in the individual trial protocols.